The SynthSolve SS-1 is ShieldTech's purpose-engineered response to a security problem that has grown significantly as synthetic human populations in GLMZ have expanded: the need for a compliance and deterrence tool specifically effective against artificial humans, whose sensory systems, dermal surfaces, and physiological responses differ fundamentally from baseline and augmented humans. Standard OC sprays, tear gas, and most pain-compliance tools have negligible effect on synthetics — their synthetic skin lacks the nerve endings that make such tools effective, their sensory arrays process chemical exposure differently, and their threat-response systems are designed to override pain signals. The SS-1 addresses this gap through a dual-action compound: a synthetic dermolytic agent (ST-Dermolyte-1) that degrades the polymeric compounds used in synthetic skin fabrication, and a secondary sensory array disruption compound (ST-SensorBlind-1) calibrated to the optical and chemical sensor frequencies common across the three major synthetic manufacturing platforms present in Meridian.

The dermolytic component produces visible surface degradation of synthetic skin — whitening, cracking, and in sustained exposures, partial delamination of the outer dermal layer. This is painful in the functional sense for synthetics whose dermal sensation arrays are active, and is also deeply distressing in a psychological sense for synthetics who have developed strong identity connections to their physical appearance. The sensory disruption component produces temporary blinding and chemical-sense interference lasting fifteen to thirty minutes. The SS-1 is not designed to destroy a synthetic — it is designed to incapacitate and mark one.

The SS-1 exists in a contested ethical and legal space that Meridian's regulatory framework handles poorly. Synthetics do not have full legal personhood, and weapons designed specifically to harm them occupy a category that current statute does not clearly address. ShieldTech markets the SS-1 as a 'synthetic compliance instrument' rather than a weapon, and this framing has so far survived legal challenge. Synthetic advocacy organizations have filed three unsuccessful injunctions against its sale.